Global Biological Drugs Market Growth 2025-2031
The global Biological Drugs market size is predicted to grow from US$ 357780 million in 2025 to US$ 583920 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Biological Drugs Industry Forecast” looks at past sales and reviews total world Biological Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Biological Drugs sales for 2025 through 2031. With Biological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Drugs industry.
This Insight Report provides a comprehensive analysis of the global Biological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Biological Drugs market?
What factors are driving Biological Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biological Drugs market opportunities vary by end market size?
How does Biological Drugs break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Biological Drugs Industry Forecast” looks at past sales and reviews total world Biological Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Biological Drugs sales for 2025 through 2031. With Biological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Drugs industry.
This Insight Report provides a comprehensive analysis of the global Biological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Biological Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Therapeutic Protein
- Monoclonal Antibody
- Vaccine
- Others
- Hospitals
- Ambulatory Surgical Centers
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- Eli Lilly
- Takeda
- Pfizer
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck
- Abbott Laboratories
- Baxter
- Novartis
- Biogen
- GlaxoSmithKline
What is the 10-year outlook for the global Biological Drugs market?
What factors are driving Biological Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biological Drugs market opportunities vary by end market size?
How does Biological Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Integrin Beta 3 Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Integrin Beta 3 by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Integrin Beta 3 by Country/Region, 2020, 2024 & 2031
2.2 Integrin Beta 3 Segment by Type
2.2.1 MSP-68
2.2.2 OCU-200
2.2.3 AC-301
2.2.4 C-16Y
2.2.5 Others
2.3 Integrin Beta 3 Sales by Type
2.3.1 Global Integrin Beta 3 Sales Market Share by Type (2020-2025)
2.3.2 Global Integrin Beta 3 Revenue and Market Share by Type (2020-2025)
2.3.3 Global Integrin Beta 3 Sale Price by Type (2020-2025)
2.4 Integrin Beta 3 Segment by Application
2.4.1 Melanoma
2.4.2 Arterial Thrombosis
2.4.3 Diabetic Macular Edema
2.4.4 Lung Cancer
2.4.5 Others
2.5 Integrin Beta 3 Sales by Application
2.5.1 Global Integrin Beta 3 Sale Market Share by Application (2020-2025)
2.5.2 Global Integrin Beta 3 Revenue and Market Share by Application (2020-2025)
2.5.3 Global Integrin Beta 3 Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Integrin Beta 3 Breakdown Data by Company
3.1.1 Global Integrin Beta 3 Annual Sales by Company (2020-2025)
3.1.2 Global Integrin Beta 3 Sales Market Share by Company (2020-2025)
3.2 Global Integrin Beta 3 Annual Revenue by Company (2020-2025)
3.2.1 Global Integrin Beta 3 Revenue by Company (2020-2025)
3.2.2 Global Integrin Beta 3 Revenue Market Share by Company (2020-2025)
3.3 Global Integrin Beta 3 Sale Price by Company
3.4 Key Manufacturers Integrin Beta 3 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Integrin Beta 3 Product Location Distribution
3.4.2 Players Integrin Beta 3 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTEGRIN BETA 3 BY GEOGRAPHIC REGION
4.1 World Historic Integrin Beta 3 Market Size by Geographic Region (2020-2025)
4.1.1 Global Integrin Beta 3 Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Integrin Beta 3 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Integrin Beta 3 Market Size by Country/Region (2020-2025)
4.2.1 Global Integrin Beta 3 Annual Sales by Country/Region (2020-2025)
4.2.2 Global Integrin Beta 3 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Integrin Beta 3 Sales Growth
4.4 APAC Integrin Beta 3 Sales Growth
4.5 Europe Integrin Beta 3 Sales Growth
4.6 Middle East & Africa Integrin Beta 3 Sales Growth
5 AMERICAS
5.1 Americas Integrin Beta 3 Sales by Country
5.1.1 Americas Integrin Beta 3 Sales by Country (2020-2025)
5.1.2 Americas Integrin Beta 3 Revenue by Country (2020-2025)
5.2 Americas Integrin Beta 3 Sales by Type (2020-2025)
5.3 Americas Integrin Beta 3 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Integrin Beta 3 Sales by Region
6.1.1 APAC Integrin Beta 3 Sales by Region (2020-2025)
6.1.2 APAC Integrin Beta 3 Revenue by Region (2020-2025)
6.2 APAC Integrin Beta 3 Sales by Type (2020-2025)
6.3 APAC Integrin Beta 3 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Integrin Beta 3 by Country
7.1.1 Europe Integrin Beta 3 Sales by Country (2020-2025)
7.1.2 Europe Integrin Beta 3 Revenue by Country (2020-2025)
7.2 Europe Integrin Beta 3 Sales by Type (2020-2025)
7.3 Europe Integrin Beta 3 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Integrin Beta 3 by Country
8.1.1 Middle East & Africa Integrin Beta 3 Sales by Country (2020-2025)
8.1.2 Middle East & Africa Integrin Beta 3 Revenue by Country (2020-2025)
8.2 Middle East & Africa Integrin Beta 3 Sales by Type (2020-2025)
8.3 Middle East & Africa Integrin Beta 3 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Integrin Beta
10.3 Manufacturing Process Analysis of Integrin Beta
10.4 Industry Chain Structure of Integrin Beta
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Integrin Beta 3 Distributors
11.3 Integrin Beta 3 Customer
12 WORLD FORECAST REVIEW FOR INTEGRIN BETA 3 BY GEOGRAPHIC REGION
12.1 Global Integrin Beta 3 Market Size Forecast by Region
12.1.1 Global Integrin Beta 3 Forecast by Region (2026-2031)
12.1.2 Global Integrin Beta 3 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Integrin Beta 3 Forecast by Type (2026-2031)
12.7 Global Integrin Beta 3 Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Factor Therapeutics Ltd
13.1.1 Factor Therapeutics Ltd Company Information
13.1.2 Factor Therapeutics Ltd Integrin Beta 3 Product Portfolios and Specifications
13.1.3 Factor Therapeutics Ltd Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Factor Therapeutics Ltd Main Business Overview
13.1.5 Factor Therapeutics Ltd Latest Developments
13.2 Merck & Co Inc
13.2.1 Merck & Co Inc Company Information
13.2.2 Merck & Co Inc Integrin Beta 3 Product Portfolios and Specifications
13.2.3 Merck & Co Inc Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck & Co Inc Main Business Overview
13.2.5 Merck & Co Inc Latest Developments
13.3 SciFluor Life Sciences LLC
13.3.1 SciFluor Life Sciences LLC Company Information
13.3.2 SciFluor Life Sciences LLC Integrin Beta 3 Product Portfolios and Specifications
13.3.3 SciFluor Life Sciences LLC Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 SciFluor Life Sciences LLC Main Business Overview
13.3.5 SciFluor Life Sciences LLC Latest Developments
13.4 SOM Biotech SL
13.4.1 SOM Biotech SL Company Information
13.4.2 SOM Biotech SL Integrin Beta 3 Product Portfolios and Specifications
13.4.3 SOM Biotech SL Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 SOM Biotech SL Main Business Overview
13.4.5 SOM Biotech SL Latest Developments
13.5 Vascular Pharmaceuticals Inc
13.5.1 Vascular Pharmaceuticals Inc Company Information
13.5.2 Vascular Pharmaceuticals Inc Integrin Beta 3 Product Portfolios and Specifications
13.5.3 Vascular Pharmaceuticals Inc Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Vascular Pharmaceuticals Inc Main Business Overview
13.5.5 Vascular Pharmaceuticals Inc Latest Developments
13.6 VDDI Pharmaceuticals
13.6.1 VDDI Pharmaceuticals Company Information
13.6.2 VDDI Pharmaceuticals Integrin Beta 3 Product Portfolios and Specifications
13.6.3 VDDI Pharmaceuticals Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 VDDI Pharmaceuticals Main Business Overview
13.6.5 VDDI Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Integrin Beta 3 Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Integrin Beta 3 by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Integrin Beta 3 by Country/Region, 2020, 2024 & 2031
2.2 Integrin Beta 3 Segment by Type
2.2.1 MSP-68
2.2.2 OCU-200
2.2.3 AC-301
2.2.4 C-16Y
2.2.5 Others
2.3 Integrin Beta 3 Sales by Type
2.3.1 Global Integrin Beta 3 Sales Market Share by Type (2020-2025)
2.3.2 Global Integrin Beta 3 Revenue and Market Share by Type (2020-2025)
2.3.3 Global Integrin Beta 3 Sale Price by Type (2020-2025)
2.4 Integrin Beta 3 Segment by Application
2.4.1 Melanoma
2.4.2 Arterial Thrombosis
2.4.3 Diabetic Macular Edema
2.4.4 Lung Cancer
2.4.5 Others
2.5 Integrin Beta 3 Sales by Application
2.5.1 Global Integrin Beta 3 Sale Market Share by Application (2020-2025)
2.5.2 Global Integrin Beta 3 Revenue and Market Share by Application (2020-2025)
2.5.3 Global Integrin Beta 3 Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Integrin Beta 3 Breakdown Data by Company
3.1.1 Global Integrin Beta 3 Annual Sales by Company (2020-2025)
3.1.2 Global Integrin Beta 3 Sales Market Share by Company (2020-2025)
3.2 Global Integrin Beta 3 Annual Revenue by Company (2020-2025)
3.2.1 Global Integrin Beta 3 Revenue by Company (2020-2025)
3.2.2 Global Integrin Beta 3 Revenue Market Share by Company (2020-2025)
3.3 Global Integrin Beta 3 Sale Price by Company
3.4 Key Manufacturers Integrin Beta 3 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Integrin Beta 3 Product Location Distribution
3.4.2 Players Integrin Beta 3 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTEGRIN BETA 3 BY GEOGRAPHIC REGION
4.1 World Historic Integrin Beta 3 Market Size by Geographic Region (2020-2025)
4.1.1 Global Integrin Beta 3 Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Integrin Beta 3 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Integrin Beta 3 Market Size by Country/Region (2020-2025)
4.2.1 Global Integrin Beta 3 Annual Sales by Country/Region (2020-2025)
4.2.2 Global Integrin Beta 3 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Integrin Beta 3 Sales Growth
4.4 APAC Integrin Beta 3 Sales Growth
4.5 Europe Integrin Beta 3 Sales Growth
4.6 Middle East & Africa Integrin Beta 3 Sales Growth
5 AMERICAS
5.1 Americas Integrin Beta 3 Sales by Country
5.1.1 Americas Integrin Beta 3 Sales by Country (2020-2025)
5.1.2 Americas Integrin Beta 3 Revenue by Country (2020-2025)
5.2 Americas Integrin Beta 3 Sales by Type (2020-2025)
5.3 Americas Integrin Beta 3 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Integrin Beta 3 Sales by Region
6.1.1 APAC Integrin Beta 3 Sales by Region (2020-2025)
6.1.2 APAC Integrin Beta 3 Revenue by Region (2020-2025)
6.2 APAC Integrin Beta 3 Sales by Type (2020-2025)
6.3 APAC Integrin Beta 3 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Integrin Beta 3 by Country
7.1.1 Europe Integrin Beta 3 Sales by Country (2020-2025)
7.1.2 Europe Integrin Beta 3 Revenue by Country (2020-2025)
7.2 Europe Integrin Beta 3 Sales by Type (2020-2025)
7.3 Europe Integrin Beta 3 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Integrin Beta 3 by Country
8.1.1 Middle East & Africa Integrin Beta 3 Sales by Country (2020-2025)
8.1.2 Middle East & Africa Integrin Beta 3 Revenue by Country (2020-2025)
8.2 Middle East & Africa Integrin Beta 3 Sales by Type (2020-2025)
8.3 Middle East & Africa Integrin Beta 3 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Integrin Beta
10.3 Manufacturing Process Analysis of Integrin Beta
10.4 Industry Chain Structure of Integrin Beta
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Integrin Beta 3 Distributors
11.3 Integrin Beta 3 Customer
12 WORLD FORECAST REVIEW FOR INTEGRIN BETA 3 BY GEOGRAPHIC REGION
12.1 Global Integrin Beta 3 Market Size Forecast by Region
12.1.1 Global Integrin Beta 3 Forecast by Region (2026-2031)
12.1.2 Global Integrin Beta 3 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Integrin Beta 3 Forecast by Type (2026-2031)
12.7 Global Integrin Beta 3 Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Factor Therapeutics Ltd
13.1.1 Factor Therapeutics Ltd Company Information
13.1.2 Factor Therapeutics Ltd Integrin Beta 3 Product Portfolios and Specifications
13.1.3 Factor Therapeutics Ltd Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Factor Therapeutics Ltd Main Business Overview
13.1.5 Factor Therapeutics Ltd Latest Developments
13.2 Merck & Co Inc
13.2.1 Merck & Co Inc Company Information
13.2.2 Merck & Co Inc Integrin Beta 3 Product Portfolios and Specifications
13.2.3 Merck & Co Inc Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck & Co Inc Main Business Overview
13.2.5 Merck & Co Inc Latest Developments
13.3 SciFluor Life Sciences LLC
13.3.1 SciFluor Life Sciences LLC Company Information
13.3.2 SciFluor Life Sciences LLC Integrin Beta 3 Product Portfolios and Specifications
13.3.3 SciFluor Life Sciences LLC Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 SciFluor Life Sciences LLC Main Business Overview
13.3.5 SciFluor Life Sciences LLC Latest Developments
13.4 SOM Biotech SL
13.4.1 SOM Biotech SL Company Information
13.4.2 SOM Biotech SL Integrin Beta 3 Product Portfolios and Specifications
13.4.3 SOM Biotech SL Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 SOM Biotech SL Main Business Overview
13.4.5 SOM Biotech SL Latest Developments
13.5 Vascular Pharmaceuticals Inc
13.5.1 Vascular Pharmaceuticals Inc Company Information
13.5.2 Vascular Pharmaceuticals Inc Integrin Beta 3 Product Portfolios and Specifications
13.5.3 Vascular Pharmaceuticals Inc Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Vascular Pharmaceuticals Inc Main Business Overview
13.5.5 Vascular Pharmaceuticals Inc Latest Developments
13.6 VDDI Pharmaceuticals
13.6.1 VDDI Pharmaceuticals Company Information
13.6.2 VDDI Pharmaceuticals Integrin Beta 3 Product Portfolios and Specifications
13.6.3 VDDI Pharmaceuticals Integrin Beta 3 Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 VDDI Pharmaceuticals Main Business Overview
13.6.5 VDDI Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biological Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biological Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Therapeutic Protein
Table 4. Major Players of Monoclonal Antibody
Table 5. Major Players of Vaccine
Table 6. Major Players of Others
Table 7. Global Biological Drugs Sales by Type (2020-2025) & (Units)
Table 8. Global Biological Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Biological Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Biological Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Biological Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Biological Drugs Sale by Application (2020-2025) & (Units)
Table 13. Global Biological Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Biological Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Biological Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Biological Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Biological Drugs Sales by Company (2020-2025) & (Units)
Table 18. Global Biological Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Biological Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Biological Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Biological Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Biological Drugs Producing Area Distribution and Sales Area
Table 23. Players Biological Drugs Products Offered
Table 24. Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Biological Drugs Sales by Geographic Region (2020-2025) & (Units)
Table 28. Global Biological Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Biological Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Biological Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Biological Drugs Sales by Country/Region (2020-2025) & (Units)
Table 32. Global Biological Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Biological Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Biological Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Biological Drugs Sales by Country (2020-2025) & (Units)
Table 36. Americas Biological Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Biological Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Biological Drugs Sales by Type (2020-2025) & (Units)
Table 39. Americas Biological Drugs Sales by Application (2020-2025) & (Units)
Table 40. APAC Biological Drugs Sales by Region (2020-2025) & (Units)
Table 41. APAC Biological Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Biological Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Biological Drugs Sales by Type (2020-2025) & (Units)
Table 44. APAC Biological Drugs Sales by Application (2020-2025) & (Units)
Table 45. Europe Biological Drugs Sales by Country (2020-2025) & (Units)
Table 46. Europe Biological Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Biological Drugs Sales by Type (2020-2025) & (Units)
Table 48. Europe Biological Drugs Sales by Application (2020-2025) & (Units)
Table 49. Middle East & Africa Biological Drugs Sales by Country (2020-2025) & (Units)
Table 50. Middle East & Africa Biological Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Biological Drugs Sales by Type (2020-2025) & (Units)
Table 52. Middle East & Africa Biological Drugs Sales by Application (2020-2025) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Biological Drugs
Table 54. Key Market Challenges & Risks of Biological Drugs
Table 55. Key Industry Trends of Biological Drugs
Table 56. Biological Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Biological Drugs Distributors List
Table 59. Biological Drugs Customer List
Table 60. Global Biological Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 61. Global Biological Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Biological Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 63. Americas Biological Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Biological Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 65. APAC Biological Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Biological Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 67. Europe Biological Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Biological Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 69. Middle East & Africa Biological Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Biological Drugs Sales Forecast by Type (2026-2031) & (Units)
Table 71. Global Biological Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Biological Drugs Sales Forecast by Application (2026-2031) & (Units)
Table 73. Global Biological Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Bristol-Myers Squibb Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Bristol-Myers Squibb Biological Drugs Product Portfolios and Specifications
Table 76. Bristol-Myers Squibb Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Main Business
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Eli Lilly Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Eli Lilly Biological Drugs Product Portfolios and Specifications
Table 81. Eli Lilly Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Eli Lilly Main Business
Table 83. Eli Lilly Latest Developments
Table 84. Takeda Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Takeda Biological Drugs Product Portfolios and Specifications
Table 86. Takeda Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Takeda Main Business
Table 88. Takeda Latest Developments
Table 89. Pfizer Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Biological Drugs Product Portfolios and Specifications
Table 91. Pfizer Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Amgen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Amgen Biological Drugs Product Portfolios and Specifications
Table 96. Amgen Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amgen Main Business
Table 98. Amgen Latest Developments
Table 99. F. Hoffmann-La Roche Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Biological Drugs Product Portfolios and Specifications
Table 101. F. Hoffmann-La Roche Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. F. Hoffmann-La Roche Main Business
Table 103. F. Hoffmann-La Roche Latest Developments
Table 104. Johnson & Johnson Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Johnson & Johnson Biological Drugs Product Portfolios and Specifications
Table 106. Johnson & Johnson Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Johnson & Johnson Main Business
Table 108. Johnson & Johnson Latest Developments
Table 109. Merck Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Merck Biological Drugs Product Portfolios and Specifications
Table 111. Merck Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. Abbott Laboratories Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Abbott Laboratories Biological Drugs Product Portfolios and Specifications
Table 116. Abbott Laboratories Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Abbott Laboratories Main Business
Table 118. Abbott Laboratories Latest Developments
Table 119. Baxter Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Baxter Biological Drugs Product Portfolios and Specifications
Table 121. Baxter Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Baxter Main Business
Table 123. Baxter Latest Developments
Table 124. Novartis Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis Biological Drugs Product Portfolios and Specifications
Table 126. Novartis Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Novartis Main Business
Table 128. Novartis Latest Developments
Table 129. Biogen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Biogen Biological Drugs Product Portfolios and Specifications
Table 131. Biogen Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Biogen Main Business
Table 133. Biogen Latest Developments
Table 134. GlaxoSmithKline Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. GlaxoSmithKline Biological Drugs Product Portfolios and Specifications
Table 136. GlaxoSmithKline Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. GlaxoSmithKline Main Business
Table 138. GlaxoSmithKline Latest Developments
Table 1. Biological Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Biological Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Therapeutic Protein
Table 4. Major Players of Monoclonal Antibody
Table 5. Major Players of Vaccine
Table 6. Major Players of Others
Table 7. Global Biological Drugs Sales by Type (2020-2025) & (Units)
Table 8. Global Biological Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Biological Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Biological Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Biological Drugs Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Biological Drugs Sale by Application (2020-2025) & (Units)
Table 13. Global Biological Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Biological Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Biological Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Biological Drugs Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Biological Drugs Sales by Company (2020-2025) & (Units)
Table 18. Global Biological Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Biological Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Biological Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Biological Drugs Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Biological Drugs Producing Area Distribution and Sales Area
Table 23. Players Biological Drugs Products Offered
Table 24. Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Biological Drugs Sales by Geographic Region (2020-2025) & (Units)
Table 28. Global Biological Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Biological Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Biological Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Biological Drugs Sales by Country/Region (2020-2025) & (Units)
Table 32. Global Biological Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Biological Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Biological Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Biological Drugs Sales by Country (2020-2025) & (Units)
Table 36. Americas Biological Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Biological Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Biological Drugs Sales by Type (2020-2025) & (Units)
Table 39. Americas Biological Drugs Sales by Application (2020-2025) & (Units)
Table 40. APAC Biological Drugs Sales by Region (2020-2025) & (Units)
Table 41. APAC Biological Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Biological Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Biological Drugs Sales by Type (2020-2025) & (Units)
Table 44. APAC Biological Drugs Sales by Application (2020-2025) & (Units)
Table 45. Europe Biological Drugs Sales by Country (2020-2025) & (Units)
Table 46. Europe Biological Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Biological Drugs Sales by Type (2020-2025) & (Units)
Table 48. Europe Biological Drugs Sales by Application (2020-2025) & (Units)
Table 49. Middle East & Africa Biological Drugs Sales by Country (2020-2025) & (Units)
Table 50. Middle East & Africa Biological Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Biological Drugs Sales by Type (2020-2025) & (Units)
Table 52. Middle East & Africa Biological Drugs Sales by Application (2020-2025) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Biological Drugs
Table 54. Key Market Challenges & Risks of Biological Drugs
Table 55. Key Industry Trends of Biological Drugs
Table 56. Biological Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Biological Drugs Distributors List
Table 59. Biological Drugs Customer List
Table 60. Global Biological Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 61. Global Biological Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Biological Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 63. Americas Biological Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Biological Drugs Sales Forecast by Region (2026-2031) & (Units)
Table 65. APAC Biological Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Biological Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 67. Europe Biological Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Biological Drugs Sales Forecast by Country (2026-2031) & (Units)
Table 69. Middle East & Africa Biological Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Biological Drugs Sales Forecast by Type (2026-2031) & (Units)
Table 71. Global Biological Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Biological Drugs Sales Forecast by Application (2026-2031) & (Units)
Table 73. Global Biological Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Bristol-Myers Squibb Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Bristol-Myers Squibb Biological Drugs Product Portfolios and Specifications
Table 76. Bristol-Myers Squibb Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bristol-Myers Squibb Main Business
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Eli Lilly Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Eli Lilly Biological Drugs Product Portfolios and Specifications
Table 81. Eli Lilly Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Eli Lilly Main Business
Table 83. Eli Lilly Latest Developments
Table 84. Takeda Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Takeda Biological Drugs Product Portfolios and Specifications
Table 86. Takeda Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Takeda Main Business
Table 88. Takeda Latest Developments
Table 89. Pfizer Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Biological Drugs Product Portfolios and Specifications
Table 91. Pfizer Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Amgen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Amgen Biological Drugs Product Portfolios and Specifications
Table 96. Amgen Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Amgen Main Business
Table 98. Amgen Latest Developments
Table 99. F. Hoffmann-La Roche Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Biological Drugs Product Portfolios and Specifications
Table 101. F. Hoffmann-La Roche Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. F. Hoffmann-La Roche Main Business
Table 103. F. Hoffmann-La Roche Latest Developments
Table 104. Johnson & Johnson Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Johnson & Johnson Biological Drugs Product Portfolios and Specifications
Table 106. Johnson & Johnson Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Johnson & Johnson Main Business
Table 108. Johnson & Johnson Latest Developments
Table 109. Merck Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Merck Biological Drugs Product Portfolios and Specifications
Table 111. Merck Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Merck Main Business
Table 113. Merck Latest Developments
Table 114. Abbott Laboratories Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Abbott Laboratories Biological Drugs Product Portfolios and Specifications
Table 116. Abbott Laboratories Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Abbott Laboratories Main Business
Table 118. Abbott Laboratories Latest Developments
Table 119. Baxter Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Baxter Biological Drugs Product Portfolios and Specifications
Table 121. Baxter Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Baxter Main Business
Table 123. Baxter Latest Developments
Table 124. Novartis Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis Biological Drugs Product Portfolios and Specifications
Table 126. Novartis Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Novartis Main Business
Table 128. Novartis Latest Developments
Table 129. Biogen Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Biogen Biological Drugs Product Portfolios and Specifications
Table 131. Biogen Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Biogen Main Business
Table 133. Biogen Latest Developments
Table 134. GlaxoSmithKline Basic Information, Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. GlaxoSmithKline Biological Drugs Product Portfolios and Specifications
Table 136. GlaxoSmithKline Biological Drugs Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. GlaxoSmithKline Main Business
Table 138. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Picture of Biological Drugs
Figure 2. Biological Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biological Drugs Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Biological Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biological Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biological Drugs Sales Market Share by Country/Region (2024)
Figure 10. Biological Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Therapeutic Protein
Figure 12. Product Picture of Monoclonal Antibody
Figure 13. Product Picture of Vaccine
Figure 14. Product Picture of Others
Figure 15. Global Biological Drugs Sales Market Share by Type in 2025
Figure 16. Global Biological Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Biological Drugs Consumed in Hospitals
Figure 18. Global Biological Drugs Market: Hospitals (2020-2025) & (Units)
Figure 19. Biological Drugs Consumed in Ambulatory Surgical Centers
Figure 20. Global Biological Drugs Market: Ambulatory Surgical Centers (2020-2025) & (Units)
Figure 21. Biological Drugs Consumed in Others
Figure 22. Global Biological Drugs Market: Others (2020-2025) & (Units)
Figure 23. Global Biological Drugs Sale Market Share by Application (2024)
Figure 24. Global Biological Drugs Revenue Market Share by Application in 2025
Figure 25. Biological Drugs Sales by Company in 2025 (Units)
Figure 26. Global Biological Drugs Sales Market Share by Company in 2025
Figure 27. Biological Drugs Revenue by Company in 2025 ($ millions)
Figure 28. Global Biological Drugs Revenue Market Share by Company in 2025
Figure 29. Global Biological Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Biological Drugs Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Biological Drugs Sales 2020-2025 (Units)
Figure 32. Americas Biological Drugs Revenue 2020-2025 ($ millions)
Figure 33. APAC Biological Drugs Sales 2020-2025 (Units)
Figure 34. APAC Biological Drugs Revenue 2020-2025 ($ millions)
Figure 35. Europe Biological Drugs Sales 2020-2025 (Units)
Figure 36. Europe Biological Drugs Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Biological Drugs Sales 2020-2025 (Units)
Figure 38. Middle East & Africa Biological Drugs Revenue 2020-2025 ($ millions)
Figure 39. Americas Biological Drugs Sales Market Share by Country in 2025
Figure 40. Americas Biological Drugs Revenue Market Share by Country (2020-2025)
Figure 41. Americas Biological Drugs Sales Market Share by Type (2020-2025)
Figure 42. Americas Biological Drugs Sales Market Share by Application (2020-2025)
Figure 43. United States Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Biological Drugs Sales Market Share by Region in 2025
Figure 48. APAC Biological Drugs Revenue Market Share by Region (2020-2025)
Figure 49. APAC Biological Drugs Sales Market Share by Type (2020-2025)
Figure 50. APAC Biological Drugs Sales Market Share by Application (2020-2025)
Figure 51. China Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. India Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Biological Drugs Sales Market Share by Country in 2025
Figure 59. Europe Biological Drugs Revenue Market Share by Country (2020-2025)
Figure 60. Europe Biological Drugs Sales Market Share by Type (2020-2025)
Figure 61. Europe Biological Drugs Sales Market Share by Application (2020-2025)
Figure 62. Germany Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. France Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Biological Drugs Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Biological Drugs Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Biological Drugs Sales Market Share by Application (2020-2025)
Figure 70. Egypt Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Biological Drugs in 2025
Figure 76. Manufacturing Process Analysis of Biological Drugs
Figure 77. Industry Chain Structure of Biological Drugs
Figure 78. Channels of Distribution
Figure 79. Global Biological Drugs Sales Market Forecast by Region (2026-2031)
Figure 80. Global Biological Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Biological Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Biological Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Biological Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Biological Drugs Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Biological Drugs
Figure 2. Biological Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biological Drugs Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Biological Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Biological Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Biological Drugs Sales Market Share by Country/Region (2024)
Figure 10. Biological Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Therapeutic Protein
Figure 12. Product Picture of Monoclonal Antibody
Figure 13. Product Picture of Vaccine
Figure 14. Product Picture of Others
Figure 15. Global Biological Drugs Sales Market Share by Type in 2025
Figure 16. Global Biological Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Biological Drugs Consumed in Hospitals
Figure 18. Global Biological Drugs Market: Hospitals (2020-2025) & (Units)
Figure 19. Biological Drugs Consumed in Ambulatory Surgical Centers
Figure 20. Global Biological Drugs Market: Ambulatory Surgical Centers (2020-2025) & (Units)
Figure 21. Biological Drugs Consumed in Others
Figure 22. Global Biological Drugs Market: Others (2020-2025) & (Units)
Figure 23. Global Biological Drugs Sale Market Share by Application (2024)
Figure 24. Global Biological Drugs Revenue Market Share by Application in 2025
Figure 25. Biological Drugs Sales by Company in 2025 (Units)
Figure 26. Global Biological Drugs Sales Market Share by Company in 2025
Figure 27. Biological Drugs Revenue by Company in 2025 ($ millions)
Figure 28. Global Biological Drugs Revenue Market Share by Company in 2025
Figure 29. Global Biological Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Biological Drugs Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Biological Drugs Sales 2020-2025 (Units)
Figure 32. Americas Biological Drugs Revenue 2020-2025 ($ millions)
Figure 33. APAC Biological Drugs Sales 2020-2025 (Units)
Figure 34. APAC Biological Drugs Revenue 2020-2025 ($ millions)
Figure 35. Europe Biological Drugs Sales 2020-2025 (Units)
Figure 36. Europe Biological Drugs Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Biological Drugs Sales 2020-2025 (Units)
Figure 38. Middle East & Africa Biological Drugs Revenue 2020-2025 ($ millions)
Figure 39. Americas Biological Drugs Sales Market Share by Country in 2025
Figure 40. Americas Biological Drugs Revenue Market Share by Country (2020-2025)
Figure 41. Americas Biological Drugs Sales Market Share by Type (2020-2025)
Figure 42. Americas Biological Drugs Sales Market Share by Application (2020-2025)
Figure 43. United States Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Biological Drugs Sales Market Share by Region in 2025
Figure 48. APAC Biological Drugs Revenue Market Share by Region (2020-2025)
Figure 49. APAC Biological Drugs Sales Market Share by Type (2020-2025)
Figure 50. APAC Biological Drugs Sales Market Share by Application (2020-2025)
Figure 51. China Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. India Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Biological Drugs Sales Market Share by Country in 2025
Figure 59. Europe Biological Drugs Revenue Market Share by Country (2020-2025)
Figure 60. Europe Biological Drugs Sales Market Share by Type (2020-2025)
Figure 61. Europe Biological Drugs Sales Market Share by Application (2020-2025)
Figure 62. Germany Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. France Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Biological Drugs Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Biological Drugs Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Biological Drugs Sales Market Share by Application (2020-2025)
Figure 70. Egypt Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Biological Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Biological Drugs in 2025
Figure 76. Manufacturing Process Analysis of Biological Drugs
Figure 77. Industry Chain Structure of Biological Drugs
Figure 78. Channels of Distribution
Figure 79. Global Biological Drugs Sales Market Forecast by Region (2026-2031)
Figure 80. Global Biological Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Biological Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Biological Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Biological Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Biological Drugs Revenue Market Share Forecast by Application (2026-2031)
